Comments
Loading...

Cellectis

CLLSNASDAQ
Logo brought to you by Benzinga Data
$2.13
-0.08-3.39%
Pre-Market: Sep 18, 7:23 PM EDT
15 minutes delayed

Cellectis (NASDAQ:CLLS) Stock Quotes, Forecast and News Summary

Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 43.19K
Day Range- - -
52 Wk Range0.96 - 3.77
Market Cap$221.15M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
42
Short Interest
0.48%
Days to Cover12.04
About Cellectis
Sector
Health Care
Industry
Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologi...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CLLS
MGNX

FAQ

Q

How do I buy Cellectis (CLLS) stock?

A

You can purchase shares of Cellectis (NASDAQ:CLLS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cellectis (CLLS) competitors?

Q

What is the forecast, or price target, for Cellectis (CLLS) stock?

A

Cellectis has a consensus price target of $9.50.

Q

What is the current price for Cellectis (CLLS)?

A

The stock price for Cellectis (NASDAQ: CLLS) is $2.135 last updated September 18, 2024 at 7:23 PM EDT.

Q

Does Cellectis (CLLS) pay a dividend?

A

There are no upcoming dividends for Cellectis.

Q

When is Cellectis (NASDAQ:CLLS) reporting earnings?

A

Cellectis’s Q3 earnings are confirmed for Monday, November 4, 2024.

Q

Is Cellectis (CLLS) going to split?

A

There is no upcoming split for Cellectis.

Q

What sector and industry does Cellectis (CLLS) operate in?

A

Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch